Delivery Order 36F79719D0160-36C24719F0823
Award Date 9/17/19
Potential Completion Date 9/30/19
Potential Value $91K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Decatur, GA 30033, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Catalyst Pharmaceuticals, Inc. was awarded a $29,691.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The firm fixed price order is for the delivery of amiFAMPRIDINE 10MG tablets to a location in Miami, Florida, with performance required by December 19, 2021. The order was placed off GSA Schedule FSS-61-IB, which provides pharmaceuticals and drugs to federal...
- This federal contract award was issued by the Veterans Integrated Service Network 20 (VISN 20), a component of the U.S. Department of Veterans Affairs (VA), to Catalyst Pharmaceuticals, Inc. The $132,865.82 firm fixed-price delivery order was placed against Catalyst's Federal Supply Schedule (FSS-61-IB) contract for the pharmaceutical product Amifampridine (Firdapse) 10mg Tablets, which is an FDA-approved treatment for Lambert-Eaton Myasthenic Syndrome (LEMS), a rare autoimmune disorder. The...
- This federal contract award to Catalyst Pharmaceuticals, Inc., doing business as Catalyst Pharmaceuticals, is for the delivery of the pharmaceutical product AMIFAMPRIDINE (FIRDAPSE) 10MG. The contract, valued at $18,526.09, was awarded by the Department of Veterans Affairs (VA) and its Veterans Health Administration (VHA) network. It is a firm fixed-price delivery order placed against Catalyst's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract has no set-aside...
- The Department of Veterans Affairs Veterans Health Administration awarded a $16,928.97 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG. Catalyst Pharmaceuticals, Inc. will provide the pharmaceutical products under its Pharmaceuticals and Drugs GSA Schedule contract with the General Services Administration. Performance will take place in Bartlett, Tennessee from December 6-8, 2023. The funding agency, VA-VHA Network 5, will utilize the products to support...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $34,394.25 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG pharmaceutical products. The firm fixed price order was placed against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule master contract vehicle. Performance will take place in Bartlett, Tennessee through March 2023. No set-aside designation was applied to this order for FIRDAPSE, a...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,080.48 delivery order to Catalyst Pharmaceuticals, Inc. for FIRDAPSE 10MG. The order was placed against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with a firm fixed price and place of performance in Miami, Florida. No set-aside designation was used for this award to the prime contractor Catalyst Pharmaceuticals for the branded drug to support...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $29,916.56 delivery order to Catalyst Pharmaceuticals, Inc. for the pharmaceutical FIRDAPSE. The order was placed against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), a multiple award schedule contract vehicle, with firm fixed pricing. Performance will take place in West Haven, Connecticut by April 30, 2021. No set aside provision was utilized for this order to supply...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,646 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG. The firm fixed price order was placed against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule, with performance at a facility in Bartlett, Tennessee. No set-aside designation was used for this order to supply the anti-neuromuscular drug Firdapse to support VHA healthcare programs in the...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Catalyst Pharmaceuticals, Inc., a for-profit pharmaceutical company specializing in rare disease therapies. The contract is for the supply of FIRDAPSE 10 MG, an FDA-approved treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder. The contract has a ceiling value of $18,978.13 and an ultimate completion date of September 29, 2025. The contract is not set-aside and is placed against...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Anovorx Distribution LLC, a small business for-profit limited liability company, to provide the medication Firdapse (Amifampridine). The contract has a potential value of $151,359.02 and a completion date of September 19, 2019. Anovorx Distribution LLC has provided various specialty pharmaceutical products to the VA and Department of the Army Medical Command...